Kansas City,
15
January
2020
|
18:29 PM
Europe/Amsterdam

Identifying Characteristics of Nonsyndromic Juvenile Polyps

Retrospective Cohort Analysis Offers New Insight

Juvenile polyps are the most common intestinal polyps diagnosed in children. Sporadic juvenile polyps, which means five or fewer polyps, are thought to harbor little malignant potential, with a low likelihood of recurrence. Because this low number of polyps has historically been considered to be benign, with no syndromic association, pediatric gastroenterologists typically have not been concerned about them. However there have been instances of pediatric patients with sporadic polyps who returned with either a recurrence of polyps or neoplastic changes, leading to concerns about future malignancies.

To date there are no established guidelines for these children, leaving gastroenterologists with questions about what to do next.

Are they truly always harmless? Should these patients be scheduled for follow-up and close monitoring?

Nadia Ibrahimi, MD, pediatric gastroenterologist at Children’s Mercy Kansas City, designed a study to= learn the answers to these questions. Her ultimate goal is to help support the establishment of new guidelines for these children.

Study Parameters

Dr. Ibrahimi and her team conducted a study in patients seen from Jan. 1, 2003, to March 1, 2017. Patients from birth through age 18 with sporadic juvenile polyps or nonsyndromic polyps (no family history of juvenile polyposis syndrome and no juvenile polyps proximal from the colon) were included. A total of 213 patients met the criteria. For those patients, a total of 326 colonoscopy procedures and 435 polypectomies were performed.

Patients were divided into three groups:

• Patients with a single juvenile polyp (n=138)

• Patients with 2-4 juvenile polyps (n=52)

• Patients with 5-10 juvenile polyps (n=23)


The team reviewed the following data:

• Basic demographics

• Age at first colonoscopy

• Clinical presentation

• Extent of colonoscopy

• Endoscopic findings, including number, size and location of polyps

• Histological findings, including size and pathologic characteristics, with dysplastic or adenomatous changes noted

• Recurrence of polyps was also noted on repeat scopes

They examined the relationship between select clinical factors and the number of polyps identified. Next, they determined whether the number of polyps was differentially distributed across patient-level factors, including gender, race, age (in months) at first scope, and clinical presentation. Finally, they compared polyp location (rectosigmoid, left, transverse and right colon), polyp volume and the presence of adenomatous transformation with the number of polyps. The slides of polyps reportedly harboring adenomatous transformation were independently reviewed by a pathologist to confirm the presence of neoplasia.

Study Sheds Light on Possible Malignancy Concerns

The study revealed that some patients can experience adenomatous changes, even when they have only one polyp. These adenomatous changes that did not correlate with the number of polyps create concerns for possible future malignant transformation. Therefore, the longstanding belief that a single sporadic juvenile polyp is not of concern must be changed. These patients likely need further follow-up and monitoring.

For patients who experienced adenomatous changes, most were found in the right, or ascending, colon. This finding supports the use of a full colonoscopy instead of flexible sigmoidoscopy to be able to find these changes and accurately identify them.

The review also showed small differences in the measurement of polyps, depending on whether they were measured by the endoscopist or pathologist. Chart data showed a tendency toward overestimation of size by the endoscopist in comparison to the pathologist. For the sake of accuracy, polyp measurement should be provided by the pathologist. The study was published in the December 2019 issue of the Journal of Pediatric Gastroenterology and Nutrition.1

Next Steps

Although this study sheds some important light on concerns related to five polyps or fewer, additional studies will be needed to support Dr. Ibrahimi’s findings. Insights from this and future studies can be used to develop consensus statements for clear guidelines that address the management of pediatric patients with sporadic juvenile polyps.

 

© Copyright 2019 The Children’s Mercy Hospital

 

Sources

1 Polyp Characteristics of Nonsyndromic and Potentially Syndromic Juvenile Polyps: A Retrospective Cohort Analysis. Ibrahimi N, Septer SS, Lee BR, Garola R, Shah R, Attard TM. J Pediatr Gastroenterol Nutr. 2019 Dec; 69(6):668-672.

 

About Us

Children’s Mercy Kansas City is an independent, non-profit, 386-bed pediatric health system, providing over half a million patient encounters each year for children from across the country. Children’s Mercy is ranked by U.S. News & World Report in nine specialties. We have received Magnet® recognition five times for excellence in nursing services. In affiliation with the University of Missouri-Kansas City, our faculty of more than 800 pediatric specialists and researchers is actively involved in clinical care, pediatric research and educating the next generation of pediatricians and pediatric subspecialists. The Children’s Mercy Research Institute (CMRI) integrates research and clinical care with nationally recognized expertise in genomic medicine, precision therapeutics, population health and health care innovation. In 2021 the CMRI moved into a nine-story, 375,000-square-foot space emphasizing a translational approach to research in which clinicians and researchers work together to accelerate the pace of discovery that enhances care.